Companion Diagnostics Market - Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: C3AC2134DB68EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Companion Diagnostics in Global, including the following market information:

Global Companion Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Companion Diagnostics market was valued at 4086.9 million in 2021 and is projected to reach US$ 9403.6 million by 2028, at a CAGR of 12.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Polymerase Chain Reaction (PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Companion Diagnostics include Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Life Technologies, GE Healthcare, Agendia, Qiagen and Genomic Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Companion Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Companion Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Companion Diagnostics Market Segment Percentages, by Type, 2021 (%)

• Polymerase Chain Reaction (PCR)
• Immunohistochemistry (IHC)
• In Situ Hybridization (ISH)
• Next Generation Sequencing (NGS)

Global Companion Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Companion Diagnostics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Pharmaceutical Companies
• Laboratories
• Other

Global Companion Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Companion Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Companion Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Companion Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche Holdings
• Abbott Laboratories
• Thermo Fisher Scientific
• Agilent Technologies
• Life Technologies
• GE Healthcare
• Agendia
• Qiagen
• Genomic Health
• Myriad Genetics
• Advanced Cell Diagnostics
• Danaher
• Applied Proteomics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Companion Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Companion Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COMPANION DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Companion Diagnostics Market Size: 2021 VS 2028
2.2 Global Companion Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Companion Diagnostics Players in Global Market
3.2 Top Global Companion Diagnostics Companies Ranked by Revenue
3.3 Global Companion Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Companion Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Companion Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Companion Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Companion Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Companion Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Companion Diagnostics Market Size Markets, 2021 & 2028
  4.1.2 Polymerase Chain Reaction (PCR)
  4.1.3 Immunohistochemistry (IHC)
  4.1.4 In Situ Hybridization (ISH)
  4.1.5 Next Generation Sequencing (NGS)
4.2 By Type - Global Companion Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Companion Diagnostics Revenue, 2017-2022
  4.2.2 By Type - Global Companion Diagnostics Revenue, 2023-2028
  4.2.3 By Type - Global Companion Diagnostics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Companion Diagnostics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Pharmaceutical Companies
  5.1.4 Laboratories
  5.1.5 Other
5.2 By Application - Global Companion Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Companion Diagnostics Revenue, 2017-2022
  5.2.2 By Application - Global Companion Diagnostics Revenue, 2023-2028
  5.2.3 By Application - Global Companion Diagnostics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Companion Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Companion Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Companion Diagnostics Revenue, 2017-2022
  6.2.2 By Region - Global Companion Diagnostics Revenue, 2023-2028
  6.2.3 By Region - Global Companion Diagnostics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Companion Diagnostics Revenue, 2017-2028
  6.3.2 US Companion Diagnostics Market Size, 2017-2028
  6.3.3 Canada Companion Diagnostics Market Size, 2017-2028
  6.3.4 Mexico Companion Diagnostics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Companion Diagnostics Revenue, 2017-2028
  6.4.2 Germany Companion Diagnostics Market Size, 2017-2028
  6.4.3 France Companion Diagnostics Market Size, 2017-2028
  6.4.4 U.K. Companion Diagnostics Market Size, 2017-2028
  6.4.5 Italy Companion Diagnostics Market Size, 2017-2028
  6.4.6 Russia Companion Diagnostics Market Size, 2017-2028
  6.4.7 Nordic Countries Companion Diagnostics Market Size, 2017-2028
  6.4.8 Benelux Companion Diagnostics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Companion Diagnostics Revenue, 2017-2028
  6.5.2 China Companion Diagnostics Market Size, 2017-2028
  6.5.3 Japan Companion Diagnostics Market Size, 2017-2028
  6.5.4 South Korea Companion Diagnostics Market Size, 2017-2028
  6.5.5 Southeast Asia Companion Diagnostics Market Size, 2017-2028
  6.5.6 India Companion Diagnostics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Companion Diagnostics Revenue, 2017-2028
  6.6.2 Brazil Companion Diagnostics Market Size, 2017-2028
  6.6.3 Argentina Companion Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Companion Diagnostics Revenue, 2017-2028
  6.7.2 Turkey Companion Diagnostics Market Size, 2017-2028
  6.7.3 Israel Companion Diagnostics Market Size, 2017-2028
  6.7.4 Saudi Arabia Companion Diagnostics Market Size, 2017-2028
  6.7.5 UAE Companion Diagnostics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche Holdings
  7.1.1 Roche Holdings Corporate Summary
  7.1.2 Roche Holdings Business Overview
  7.1.3 Roche Holdings Companion Diagnostics Major Product Offerings
  7.1.4 Roche Holdings Companion Diagnostics Revenue in Global Market (2017-2022)
  7.1.5 Roche Holdings Key News
7.2 Abbott Laboratories
  7.2.1 Abbott Laboratories Corporate Summary
  7.2.2 Abbott Laboratories Business Overview
  7.2.3 Abbott Laboratories Companion Diagnostics Major Product Offerings
  7.2.4 Abbott Laboratories Companion Diagnostics Revenue in Global Market (2017-2022)
  7.2.5 Abbott Laboratories Key News
7.3 Thermo Fisher Scientific
  7.3.1 Thermo Fisher Scientific Corporate Summary
  7.3.2 Thermo Fisher Scientific Business Overview
  7.3.3 Thermo Fisher Scientific Companion Diagnostics Major Product Offerings
  7.3.4 Thermo Fisher Scientific Companion Diagnostics Revenue in Global Market (2017-2022)
  7.3.5 Thermo Fisher Scientific Key News
7.4 Agilent Technologies
  7.4.1 Agilent Technologies Corporate Summary
  7.4.2 Agilent Technologies Business Overview
  7.4.3 Agilent Technologies Companion Diagnostics Major Product Offerings
  7.4.4 Agilent Technologies Companion Diagnostics Revenue in Global Market (2017-2022)
  7.4.5 Agilent Technologies Key News
7.5 Life Technologies
  7.5.1 Life Technologies Corporate Summary
  7.5.2 Life Technologies Business Overview
  7.5.3 Life Technologies Companion Diagnostics Major Product Offerings
  7.5.4 Life Technologies Companion Diagnostics Revenue in Global Market (2017-2022)
  7.5.5 Life Technologies Key News
7.6 GE Healthcare
  7.6.1 GE Healthcare Corporate Summary
  7.6.2 GE Healthcare Business Overview
  7.6.3 GE Healthcare Companion Diagnostics Major Product Offerings
  7.6.4 GE Healthcare Companion Diagnostics Revenue in Global Market (2017-2022)
  7.6.5 GE Healthcare Key News
7.7 Agendia
  7.7.1 Agendia Corporate Summary
  7.7.2 Agendia Business Overview
  7.7.3 Agendia Companion Diagnostics Major Product Offerings
  7.7.4 Agendia Companion Diagnostics Revenue in Global Market (2017-2022)
  7.7.5 Agendia Key News
7.8 Qiagen
  7.8.1 Qiagen Corporate Summary
  7.8.2 Qiagen Business Overview
  7.8.3 Qiagen Companion Diagnostics Major Product Offerings
  7.8.4 Qiagen Companion Diagnostics Revenue in Global Market (2017-2022)
  7.8.5 Qiagen Key News
7.9 Genomic Health
  7.9.1 Genomic Health Corporate Summary
  7.9.2 Genomic Health Business Overview
  7.9.3 Genomic Health Companion Diagnostics Major Product Offerings
  7.9.4 Genomic Health Companion Diagnostics Revenue in Global Market (2017-2022)
  7.9.5 Genomic Health Key News
7.10 Myriad Genetics
  7.10.1 Myriad Genetics Corporate Summary
  7.10.2 Myriad Genetics Business Overview
  7.10.3 Myriad Genetics Companion Diagnostics Major Product Offerings
  7.10.4 Myriad Genetics Companion Diagnostics Revenue in Global Market (2017-2022)
  7.10.5 Myriad Genetics Key News
7.11 Advanced Cell Diagnostics
  7.11.1 Advanced Cell Diagnostics Corporate Summary
  7.11.2 Advanced Cell Diagnostics Business Overview
  7.11.3 Advanced Cell Diagnostics Companion Diagnostics Major Product Offerings
  7.11.4 Advanced Cell Diagnostics Companion Diagnostics Revenue in Global Market (2017-2022)
  7.11.5 Advanced Cell Diagnostics Key News
7.12 Danaher
  7.12.1 Danaher Corporate Summary
  7.12.2 Danaher Business Overview
  7.12.3 Danaher Companion Diagnostics Major Product Offerings
  7.12.4 Danaher Companion Diagnostics Revenue in Global Market (2017-2022)
  7.12.5 Danaher Key News
7.13 Applied Proteomics
  7.13.1 Applied Proteomics Corporate Summary
  7.13.2 Applied Proteomics Business Overview
  7.13.3 Applied Proteomics Companion Diagnostics Major Product Offerings
  7.13.4 Applied Proteomics Companion Diagnostics Revenue in Global Market (2017-2022)
  7.13.5 Applied Proteomics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Companion Diagnostics Market Opportunities & Trends in Global Market
Table 2. Companion Diagnostics Market Drivers in Global Market
Table 3. Companion Diagnostics Market Restraints in Global Market
Table 4. Key Players of Companion Diagnostics in Global Market
Table 5. Top Companion Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Companion Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Companion Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Companion Diagnostics Product Type
Table 9. List of Global Tier 1 Companion Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Companion Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Companion Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Companion Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Companion Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Companion Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Companion Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Companion Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Companion Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Companion Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Companion Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Companion Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Companion Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Companion Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Companion Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Companion Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Companion Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Companion Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Companion Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Companion Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Companion Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Roche Holdings Corporate Summary
Table 31. Roche Holdings Companion Diagnostics Product Offerings
Table 32. Roche Holdings Companion Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Companion Diagnostics Product Offerings
Table 35. Abbott Laboratories Companion Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Companion Diagnostics Product Offerings
Table 38. Thermo Fisher Scientific Companion Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Agilent Technologies Corporate Summary
Table 40. Agilent Technologies Companion Diagnostics Product Offerings
Table 41. Agilent Technologies Companion Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Life Technologies Corporate Summary
Table 43. Life Technologies Companion Diagnostics Product Offerings
Table 44. Life Technologies Companion Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. GE Healthcare Corporate Summary
Table 46. GE Healthcare Companion Diagnostics Product Offerings
Table 47. GE Healthcare Companion Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Agendia Corporate Summary
Table 49. Agendia Companion Diagnostics Product Offerings
Table 50. Agendia Companion Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Qiagen Corporate Summary
Table 52. Qiagen Companion Diagnostics Product Offerings
Table 53. Qiagen Companion Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Genomic Health Corporate Summary
Table 55. Genomic Health Companion Diagnostics Product Offerings
Table 56. Genomic Health Companion Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. Myriad Genetics Corporate Summary
Table 58. Myriad Genetics Companion Diagnostics Product Offerings
Table 59. Myriad Genetics Companion Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. Advanced Cell Diagnostics Corporate Summary
Table 61. Advanced Cell Diagnostics Companion Diagnostics Product Offerings
Table 62. Advanced Cell Diagnostics Companion Diagnostics Revenue (US$, Mn), (2017-2022)
Table 63. Danaher Corporate Summary
Table 64. Danaher Companion Diagnostics Product Offerings
Table 65. Danaher Companion Diagnostics Revenue (US$, Mn), (2017-2022)
Table 66. Applied Proteomics Corporate Summary
Table 67. Applied Proteomics Companion Diagnostics Product Offerings
Table 68. Applied Proteomics Companion Diagnostics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Companion Diagnostics Segment by Type in 2021
Figure 2. Companion Diagnostics Segment by Application in 2021
Figure 3. Global Companion Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Companion Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Companion Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Companion Diagnostics Revenue in 2021
Figure 8. By Type - Global Companion Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Companion Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Companion Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Companion Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Companion Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Companion Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Companion Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Companion Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Companion Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Holdings Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Laboratories Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Agilent Technologies Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Life Technologies Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GE Healthcare Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Agendia Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Qiagen Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Genomic Health Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Myriad Genetics Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Advanced Cell Diagnostics Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Danaher Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Applied Proteomics Companion Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)